enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Targeted therapy may help treat moderate to severe ulcerative ...

    www.aol.com/targeted-therapy-may-help-treat...

    Participants in the trial were ages 18 or older and either had a dependence on glucocorticoids for treatment or had not had success with certain medications for ulcerative colitis treatment.

  3. FDA-approved drug for ulcerative colitis also effective for ...

    www.aol.com/fda-approved-drug-ulcerative-colitis...

    Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.

  4. Ozanimod - Wikipedia

    en.wikipedia.org/wiki/Ozanimod

    Touchstone is a double-blind, placebo controlled phase II clinical for the treatment of ulcerative colitis. [ 24 ] [ 25 ] 197 patients, ages 18–75, with moderate to severe ulcerative colitis (Mayo Score 6–10) were recruited and assigned either placebo, 0.5 mg or 1 mg of oral ozanimod followed by 1 week of dose escalation.

  5. Mercaptopurine - Wikipedia

    en.wikipedia.org/wiki/Mercaptopurine

    Specifically it is used to treat acute lymphocytic leukemia (ALL), acute promyelocytic leukemia (APL), Crohn's disease, and ulcerative colitis. [2] [3] For acute lymphocytic leukemia it is generally used with methotrexate. [2] It is taken orally. [2] Common side effects include bone marrow suppression, liver toxicity, vomiting, and loss of ...

  6. Vedolizumab - Wikipedia

    en.wikipedia.org/wiki/Vedolizumab

    Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Takeda Oncology for the treatment of ulcerative colitis and Crohn's disease. [5] It binds to integrin α 4 β 7 ( LPAM-1 , lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7 ), [ 5 ] [ 6 ] blocking the α 4 ...

  7. FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis ...

    www.aol.com/finance/fda-approves-expanded-eli...

    Omvoh is now approved in the U.S. for two types of inflammatory bowel disease (IBD), following its October 2023 approval as a first-in-class treatment for moderately to severely active ulcerative ...

  8. Infliximab - Wikipedia

    en.wikipedia.org/wiki/Infliximab

    The Acute ulcerative Colitis Treatment trials (ACT1 and ACT2) to evaluate the utility of infliximab in ulcerative colitis showed 44–45% of patients treated with infliximab for a year maintained a response to the medication, compared with 21% of patients who were treated with placebo medication.

  9. Filgotinib - Wikipedia

    en.wikipedia.org/wiki/Filgotinib

    Due to concerns over testicular toxicity in males, the MANTA study is examining the safety of the drug in the context of treating ulcerative colitis. [ 29 ] [ full citation needed ] Despite these concerns, the FDA allowed a 200-mg daily dose for males in the Phase III FINCH trials.